Ask sales for the lot-numbered COA matched to the offered or supplied batch; it records the tests actually completed, their specifications, and the reported results.
Review the matching batch COA for the analytical scope and results recorded for that lot.
Matching batch COA available.
PCAC will review 7 peptides for the 503A bulks list, BPC-157, KPV, TB-500, MOTS-c, Emideltide, Semax, Epitalon. Read our briefing →
PCAC will review 7 peptides for the 503A bulks list. Read →
FDA PCAC reviews 7 peptides in July. Read →
CJC-1295, Ipamorelin, Sermorelin, Tesamorelin, GHRP-2/6 and other growth-hormone-axis research peptides and blends.
Modified GRF 1-29 · GHRH analog
Ghrelin / GHSR pathway GH-release peptide
29-mer
GHRH 1-29 fragment
Modified HGH fragment 176–191 (anti-obesity drug candidate)
16-mer
C-terminal fragment of human growth hormone (176–191)
Long-acting GHRH analog with Drug Affinity Complex
Growth-hormone-releasing peptide-2 · Pralmorelin
Growth-hormone-releasing peptide-6
57-mer
GHRH analog · approved for HIV-associated lipodystrophy
191-mer
Recombinant human growth hormone · 191-amino-acid somatropin
Long-Arg3 IGF-1 (long-acting IGF-1 analog)
IGF-1 Ec splice-variant peptide
24-mer
Potent GHRP hexapeptide · GH-secretagogue research
Applications & buyer fit
GH-axis peptides ship to two main buyer types: compounding pharmacies dispensing under physician supervision, and research labs studying somatotropic-axis pharmacology. Pharmacies typically want sterile-filled vials with the full release packet (sterility, endotoxin, CCI); labs typically want bulk lyophilized powder with sequence verification. Blends (the CJC-1295 / Ipamorelin combination is the canonical example) are usually co-lyophilized rather than solution-mixed for potency stability.
Buyer types across this category
Documentation available for this class
Sold as a bulk active for research and for compounding-pharmacy formulation where local regulations permit (notably 503A / 503B in the United States and analogous regimes elsewhere). Not a finished dosage form. Sterile-filled vials are available with full release documentation; the buyer is responsible for verifying scheduling and dispense requirements in the destination market.